EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Type I interferon signaling induces a delayed antiproliferative response in respiratory epithelial cells during SARS-CoV-2 infection

Juliana Bragazzi Cunha, Kyle Leix, Emily J Sherman, Carmen Mirabelli, Tristan Frum, Charles J Zhang, Andrew A Kennedy, Adam S Lauring, Andrew W Tai iD, Jonathan Z Sexton iD, Jason R Spence, Christiane E Wobus iD und 1 weitere

Journal of Virology · 21.12.2023 · 97 (12)

DOI: 10.1128/jvi.01276-23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Virology, erschienen am 21.12.2023. Verfasst von Juliana Bragazzi Cunha und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA. Hauptthemen laut MEDLINE: COVID-19, Epithelial Cells, Interferon Type I, Lung. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NIDDK NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Disease progression during SARS-CoV-2 infection is tightly linked to the fate of lung epithelial cells, with severe cases of COVID-19 characterized by direct injury of the alveolar epithelium and an impairment in its regeneration from progenitor cells. The molecular pathways that govern respiratory epithelial cell death and proliferation during SARS-CoV-2 infection, however, remain unclear. We now report a high-throughput CRISPR screen for host genetic modifiers of the survival and proliferation of SARS-CoV-2-infected Calu-3 respiratory epithelial cells. The top four genes identified in our screen encode components of the same type I interferon (IFN-I) signaling complex —IFNAR1 , IFNAR2 , JAK1 , and TYK2 . The fifth gene, ACE2 , was an expected control encoding the SARS-CoV-2 viral receptor. Surprisingly, despite the antiviral properties of IFN-I signaling, its disruption in our screen was associated with an increase in Calu-3 cell fitness. We validated this effect and found that IFN-I signaling did not sensitize SARS-CoV-2-infected cultures to cell death but rather inhibited the proliferation of surviving cells after the early peak of viral replication and cytopathic effect. We also found that IFN-I signaling alone, in the absence of viral infection, was sufficient to induce this delayed antiproliferative response in both Calu-3 cells and iPSC-derived type 2 alveolar epithelial cells. Together, these findings highlight a cell autonomous antiproliferative response by respiratory epithelial cells to persistent IFN-I signaling during SARS-CoV-2 infection. This response may contribute to the deficient alveolar regeneration that has been associated with COVID-19 lung injury and represents a promising area for host-targeted therapeutic development. IMPORTANCE The proliferation of respiratory epithelial cells is crucial to host recovery from acute lung injury caused by SARS-CoV-2 and other viral pathogens, but the molecular pathways that govern this process are poorly understood. We performed a high-throughput CRISPR screen that surprisingly revealed a detrimental effect of specific host response, type I interferon (IFN-I) signaling, on the fitness of SARS-CoV-2-infected Calu-3 cells. While IFN-I signaling has been previously associated with several potential downstream responses, we found this effect to be primarily mediated by an inhibition of Calu-3 cellular proliferation after the early peak of SARS-CoV-2-induced cell death. Our findings provide a plausible mechanism for how sustained IFN-I signaling during SARS-CoV-2 infection might worsen lung pathology by blocking the regeneration of the alveolar epithelium from progenitor cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Epithelial CellsInterferon Type ILungHumansSARS-CoV-2Cell LineCell Proliferation

Stichwörter der Autor:innen

CRISPR screenSARS-CoV-2cell proliferationinterferon

Substanzen

Interferon Type I

Autor:innen und Institutionen

  • Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA.
  • Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, Michigan, USA.
  • Department of Medicinal Chemistry, College of Pharmacy, University of Michigan, Ann Arbor, Michigan, USA.
  • VA Ann Arbor Healthcare System, Ann Arbor, Michigan, USA.
  • Department of Cell and Developmental Biology, University of Michigan Medical School, Ann Arbor, Michigan, USA.
  • Department of Biomedical Engineering, University of Michigan College of Engineering, Ann Arbor, Michigan, USA.

ORCID-Profile: Andrew W Tai, Jonathan Z Sexton, Christiane E Wobus, Brian T Emmer

Förderung

  • NHLBI NIH HHS
  • NIDDK NIH HHS
  • NIGMS NIH HHS
  • HHS | NIH | National Heart, Lung, and Blood Institute
  • HHS | NIH | National Institute of General Medical Sciences
  • A. Alfred Taubman Medical Research Institute
  • UM | Michigan Institute for Clinical and Health Research
  • Marie-Slodowska Curie Global Fellowship

Zitieren

APA

Bragazzi Cunha, J., Leix, K., Sherman, E. J., Mirabelli, C., Frum, T., Zhang, C. J., Kennedy, A. A., Lauring, A. S., Tai, A. W., Sexton, J. Z., Spence, J. R., Wobus, C. E., & Emmer, B. T. (2023). Type I interferon signaling induces a delayed antiproliferative response in respiratory epithelial cells during SARS-CoV-2 infection. Journal of Virology, 97(12). https://doi.org/10.1128/jvi.01276-23

Vancouver

Bragazzi Cunha J, Leix K, Sherman EJ, Mirabelli C, Frum T, Zhang CJ, et al. Type I interferon signaling induces a delayed antiproliferative response in respiratory epithelial cells during SARS-CoV-2 infection. Journal of Virology. 2023;97(12). doi:10.1128/jvi.01276-23

BibTeX
@article{BragazziCunha2023,
  author = {Bragazzi Cunha, Juliana and Leix, Kyle and Sherman, Emily J and Mirabelli, Carmen and Frum, Tristan and Zhang, Charles J and Kennedy, Andrew A and Lauring, Adam S and Tai, Andrew W and Sexton, Jonathan Z and Spence, Jason R and Wobus, Christiane E and Emmer, Brian T},
  title = {Type I interferon signaling induces a delayed antiproliferative response in respiratory epithelial cells during SARS-CoV-2 infection},
  journal = {Journal of Virology},
  year = {2023},
  volume = {97},
  number = {12},
  doi = {10.1128/jvi.01276-23}
}
Kostenlos starten →